Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators
Mallick et al • 2023 • Transl Res.
© 2024 Corcept Therapeutics, Incorporated
ROSELLA, GOG‑3073, ENGOT‑OV72/MITO: A Phase 3 Study of Relacorilant + Nab‑paclitaxel vs. Nab‑paclitaxel in Advanced, Platinum-resistant Ovarian Cancer
Alexander Olawaiye et al. • 2023 • SGO Annual Meeting 2023